Kurisu K, Hishikawa Y, Miura T, Kanno H, Okamoto E
Department of Radiology, Hyogo College of Medicine, Japan.
Radiat Med. 1991 Mar-Apr;9(2):82-4.
The case of a patient with bile duct carcinoma who had a postoperative residual tumor treated with high-dose-rate intraluminal brachytherapy (HDRIBT) following external radiotherapy is presented. Following radiotherapy, he has been alive and well without signs of recurrence for two years and eleven months as of this writing. HDRIBT following external irradiation is recommended for the treatment of postoperative small residual tumors of the bile duct.
本文介绍了一例胆管癌患者的病例,该患者在接受外照射放疗后,对术后残留肿瘤采用高剂量率腔内近距离放疗(HDRIBT)进行治疗。截至撰写本文时,放疗后他一直存活且状况良好,没有复发迹象。对于胆管术后小的残留肿瘤,建议在体外照射后进行HDRIBT治疗。